| Patient | Frances Burney |
|---|---|
| Date of birth | 1967-06-13 |
| Identifiers | MRN HR-EN013-SYN; SSN (made up) 000-13-9108 |
| Document date | 2026-08-24 |
| Author | Harriet Pell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review of breast imaging and biopsy results. [S]
Mrs. Burney returns two weeks after presenting with a right breast lump and a year of heavy, dull breast ache. The diagnostic mammogram and ultrasound twelve days ago showed a 2.4 cm spiculated mass at 10 o'clock in the right breast, BI-RADS 5, with normal axillary nodes and dense breast tissue. The ultrasound-guided core biopsy ten days ago shows invasive ductal carcinoma, grade 2, strongly estrogen and progesterone receptor positive and HER2 negative. The ache is unchanged and does not wake her. She has no bone pain, cough, headaches, abdominal pain, or weight loss. She saw Dr. Marsh of breast surgery this morning. She is frightened of an operation and has asked that every step be explained beforehand and that she be warned before anything is done; with that, she feels able to go ahead. She has no family history of breast or ovarian cancer that she knows of, but her mother died when she was ten and little is known of her mother's family. [S]
| Element | Detail |
|---|---|
| Interval change | Imaging BI-RADS 5; core biopsy invasive ductal carcinoma, ER and PR positive, HER2 negative |
| Symptoms | Unchanged dull ache; no symptoms of spread |
| Coordination | Breast surgery seen this morning |
| Family history | Limited: mother died when she was ten |
| Concerns | Fear of surgery; wants each step explained and to be warned in advance |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight loss, fever, or night sweats |
| Breast | Positive | Right breast lump with a dull ache; no nipple discharge or skin change |
| Musculoskeletal | Negative | No bone pain |
| Respiratory | Negative | No cough or breathlessness |
| Neurological | Negative | No headaches |
| Psychiatric | Positive | Worried and sleeping less since the diagnosis; PHQ-9 5, GAD-7 7 |
6 systems reviewed. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-24 | Body height | 160 | cm | S |
| 2026-08-24 | Body weight | 61.6 | kg | S |
| 2026-08-24 | Body mass index (BMI) [Ratio] | 24.1 | kg/m2 | S |
| 2026-08-24 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-08-24 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-08-24 | Heart rate | 86 | /min | S |
| 2026-08-24 | Respiratory rate | 14 | /min | S |
| 2026-08-24 | Body temperature | 36.6 | Cel | S |
| 2026-08-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-24 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2026-08-24 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 7 | {score} | S |
Vital signs recorded on 2026-08-24; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Anxious but composed |
| Breasts | Right breast: 2.5 cm hard, irregular mass at 10 o'clock, mobile on the chest wall, with a small bruise from the biopsy; no skin dimpling or nipple change. Left breast normal |
| Lymph nodes | No axillary, supraclavicular, or infraclavicular nodes |
| Abdomen | Soft; liver not enlarged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Invasive ductal carcinoma of the right breast, upper outer quadrant at 10 o'clock, presenting as a firm lump after about a year of breast ache; core biopsy: grade 2, estrogen and progesterone receptor positive, HER2 negative; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern diagnosis linked to the documented 1811 breast disease and mastectomy, whose cancer diagnosis is debated | active | confirmed | C50.411 | S — Synthetic diagnosis confirmed by biopsy and surgical pathology in the modern episode; whether her historical disease was cancer remains a retrospective interpretation (R). |
| Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 70 percent) | active | confirmed | Z17.0 | S — Synthetic receptor result; no tissue from her lifetime was examined. |
| Firm lump in the upper outer quadrant of the right breast after about a year of heavy breast ache; clinically suspicious, imaging and biopsy booked | resolved | confirmed | N63.11 | S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the year of breast ache echoes her documented account (D). |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Diagnostic mammography and ultrasound of the breast and axilla | At presentation with a palpable mass | Up to date | Done twelve days ago: 2.4 cm spiculated mass, BI-RADS 5; normal axillary nodes; dense breasts |
| Laboratory | Core biopsy with ER, PR, and HER2 testing | At diagnosis | Up to date | Invasive ductal carcinoma, grade 2; ER 95 percent, PR 70 percent, HER2 1+ (negative), Ki-67 15 percent |
| Imaging | Breast MRI for extent of disease | Optional at diagnosis; considered for dense breasts or when surgical planning is uncertain | Ordered | Booked in four days |
| Imaging | CT, bone scan, or PET for distant spread | Only with symptoms or clinical stage III | Not indicated | Clinical stage T2 N0 with no symptoms of spread |
| Laboratory | Tumor markers (CEA, CA 15-3, CA 27.29) | Not recommended for early breast cancer | Not indicated | Not ordered |
| Laboratory | Germline genetic testing | At diagnosis, for breast cancer at 65 or younger | Completed today | Multigene panel sample sent today; result expected in about three weeks, before surgery |
| Survey | Distress, depression, and anxiety screen (PHQ-9 and GAD-7) | At diagnosis and at periodic intervals | Completed today | PHQ-9 5 and GAD-7 7, mild; supported today and offered the cancer center's counseling service |
| Examination | Lymphedema baseline arm measurements | Before axillary surgery | Due | To be measured at the pre-anesthesia visit before surgery |
| Referral | Breast surgery | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Referral | Medical oncology | After surgery, with the surgical pathology | Due | To review the pathology and recurrence score after surgery |
| Medication safety | Pre-anesthesia evaluation | Before surgery | Ordered | Pre-anesthesia clinic visit to be booked once the date is set |
| Self-management | Activity and preparation for surgery | Every visit | Completed today | Walking 30 minutes a day; never smoker; shoulder exercise leaflet given |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol 2024 (2024); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)
Follow-up: Breast MRI in four days. Genetic result in about three weeks. Surgery date from the breast surgery team. Primary care review about three weeks after surgery. Next scheduled visit 2026-10-19: review three weeks after right mastectomy; start of endocrine therapy and survivorship care. [S]